-
2024-519521-37-01
10
2025-07-30
Acute ischemic stroke
-
2024-520154-38-00
5
2025-07-29
Acute Myeloid Luekemia
-
2024-511667-28-00
1
2025-07-21
Plasma cell myeloma refractory
-
2024-519322-20-00
5
2025-07-21
metastatic colorectal cancer
-
2024-516162-11-00
5
2025-07-14
Endocrine-Sensitive phosphatidylinositol 3-kinase (PIK3CA)-Mutated, Ho
-
2024-512981-33-00
4
2025-07-09
Metastatic Colorectal Cancer
-
2024-517247-31-00
5
2025-07-07
Newly Diagnosed Higher Risk Myelodysplastic Syndrome
-
2024-517789-41-00
6
2025-07-04
metastatic or locally advanced renal cell carcinoma
-
2024-518289-28-00
4
2025-07-04
Progressive pulmonary fibrosis [PPF]
Idiopathic pulmonary fibrosis [I
-
2024-516633-12-00
5
2025-06-30
Locally advanced/ metastatic gastroesophageal junction and gastric can
-
2024-514539-67-00
4
2025-06-27
Systemic Sclerosis
-
2024-513111-27-00
5
2025-06-26
Psoriatic Arthritis
-
2025-520705-12-00
4
2025-06-24
Colitis Ulcerative
-
2024-517423-40-00
5
2025-06-23
Metastatic Castration-Resistant Prostate Cancer
-
2024-517450-95-00
5
2025-06-23
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)
-
2023-507260-40-00
7
2025-06-16
Hemophilia B
-
2024-513122-27-00
5
2025-06-10
Unresectable, Locally Advanced or Metastatic HER2 positive Gastric or
-
2023-509391-42-00
11
2025-06-02
Chron's Disease
-
2023-506539-14-00
3
2025-05-27
Oncology
-
2023-504478-39-00
5
2025-05-23
Squamous cell carcinoma of head and neck
-
2024-515526-89-00
4
2025-05-16
Diffuse Large B-Cell Lymphoma (DLBCL)
-
2023-510155-37-00
5
2025-05-08
Hypomethylating agent (HMA) naive myelodysplastic syndromes
Myelodyspl
-
2024-515459-39-00
7
2025-05-08
Advanced or Metastatic Squamous Solid Tumors
-
2023-506460-14-00
5
2025-05-07
Chronic kidney disease (CKD) and hypertension.